Suppr超能文献

内皮素-1 调控细支气管炎性闭塞综合征支气管肺泡灌洗肺间充质干细胞的增殖和迁移。

Endothelin-1 governs proliferation and migration of bronchoalveolar lavage-derived lung mesenchymal stem cells in bronchiolitis obliterans syndrome.

机构信息

Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria.

出版信息

Transplantation. 2011 Jul 27;92(2):155-62. doi: 10.1097/TP.0b013e318222c9ea.

Abstract

BACKGROUND

Bronchiolitis obliterans syndrome (BOS) has an incidence of 57% at 5 years after lung transplantation, accounts for 30% of all deaths 3 years posttransplant and because treatment options are extremely limited, it constitutes a significant health care problem. Adult mesenchymal stem cells (MSCs) play a role in lung turnover; however, their role in BOS remains unknown.

METHODS

MSCs were isolated from bronchoalveolar lavage (BAL) in 101 lung allograft recipients. BAL was screened by protein array and MSCs were analyzed by real-time polymerase chain reaction, proliferation, migration, and enzyme linked immunosorbent assays.

RESULTS

Multipotent MSCs were isolated from BAL of lung recipients independent of BOS presence. However, MSCs from BOS patients proliferated at higher rates (P<0.001) and were associated with higher α-smooth muscle actin (P = 0.03) but lower surfactant protein B (P = 0.02) compared with those from no-BOS patients. Histological analysis revealed that MSCs are abundant in lung tissue of BOS patients. MSCs from BOS patients produced higher endothelin-1 (ET-1) amounts (P<0.001) compared with those from no-BOS; and ET-1 stimulated whereas ET-1 blockade suppressed MSC proliferation, migration, and differentiation.

CONCLUSIONS

These results indicate that MSCs are associated with BOS and are governed by ET-1. Targeting MSCs by ET-1 blockade might be useful in BOS treatment.

摘要

背景

肺移植后 5 年内,闭塞性细支气管炎综合征(BOS)的发病率为 57%,占移植后 3 年内所有死亡人数的 30%,由于治疗选择极为有限,因此构成了一个重大的医疗保健问题。成人间充质干细胞(MSCs)在肺更新中起作用;然而,它们在 BOS 中的作用尚不清楚。

方法

从 101 例肺移植受者的支气管肺泡灌洗液(BAL)中分离出 MSCs。通过蛋白质芯片筛选 BAL,并通过实时聚合酶链反应、增殖、迁移和酶联免疫吸附试验分析 MSCs。

结果

从肺受体的 BAL 中独立分离出多能 MSCs,而与无 BOS 患者相比,BOS 患者的 MSCs 增殖速度更快(P<0.001),并且与更高的α-平滑肌肌动蛋白(P = 0.03)和更低的表面活性蛋白 B(P = 0.02)相关。组织学分析显示,BOS 患者的肺组织中 MSCs 丰富。BOS 患者的 MSCs 产生的内皮素-1(ET-1)量更高(P<0.001),而 ET-1 刺激而 ET-1 阻断抑制 MSC 增殖、迁移和分化。

结论

这些结果表明 MSCs 与 BOS 相关,并受 ET-1 调控。通过 ET-1 阻断靶向 MSCs 可能对 BOS 治疗有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验